Pharmhouse Corp
Statements
Balance Sheet
Pharmhouse Corp (PHSE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 54 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q1 21 | Q2 21 | Q3 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 28 | 6.6 | 6.6 | 6.6 | 6.6 | 3.9 | 3.9 | 3.9 | 3.9 | – | – | 0.1 | 0.1 | 0.5 | 0.4 | 0.7 | 0.6 | 0.4 | 21 | 60 | 63 | 54 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 12 | 6.0 | 6.0 | 6.0 | 5.9 | 3.2 | 3.2 | 3.2 | 3.2 | – | – | 0.1 | 0.0 | 0.3 | 0.1 | 0.4 | 0.2 | 0.0 | 0.5 | 10 | 13 | 3.8 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.8 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | 0.1 | 0.0 | 0.3 | 0.1 | 0.4 | 0.2 | 0.0 | 0.1 | 0.2 | 0.0 | 0.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.8 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | 0.1 | 0.0 | 0.3 | 0.1 | 0.4 | 0.2 | 0.0 | 0.1 | 0.2 | 0.0 | 0.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.2 | 0.3 | 0.2 | 0.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 11 | 5.9 | 5.9 | 5.9 | – | – | – | 3.2 | 3.2 | – | – | – | – | – | – | – | – | – | 0.2 | 0.1 | 0.1 | 0.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 16 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 24 | 24 | 24 | |
| – | – | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.1 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | – | 6.5 | 6.5 | 6.4 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | 0.4 | 0.4 | – | 0.4 | 0.5 | 0.9 | 1.0 | 1.7 | 1.8 | 2.8 | 2.1 | 8.0 | 8.2 | 7.4 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | 0.4 | 0.4 | – | 0.4 | 0.5 | 0.9 | 1.0 | 1.7 | 1.8 | 2.8 | 2.1 | 7.9 | 8.1 | 7.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | – | – | – | – | – | – | 0.1 | 0.1 | 0.1 | – | 0.4 | 0.5 | 0.9 | 0.9 | 1.4 | 1.4 | 1.3 | 1.6 | 4.7 | 5.1 | 4.5 | |
| – | – | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.3 | 0.3 | – | – | – | – | – | – | – | – | 0.2 | 0.9 | 1.6 | 2.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 28 | 6.5 | 6.5 | 6.5 | 6.5 | 3.8 | 3.8 | 3.5 | 3.5 | -0.4 | – | -0.2 | -0.4 | -0.4 | -0.6 | -1.0 | -1.2 | -2.4 | 19 | 52 | 55 | 46 | |
| -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | – | – | -2.3 | 5.6 | 5.5 | 5.5 | -7.0 | -9.7 | -9.7 | -10.0 | -10 | -13 | – | -12 | -13 | -13 | -13 | -13 | -13 | -15 | -16 | -24 | -27 | -37 | |
| 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 27 | 66 | 93 | 94 | 94 | – | 94 | – | 94 | 94 | 128 | 142 | 208 | 840 | 849 | 852 | 852 | 852 | 861 | 1,516 | 1,533 | 2,212 | 2,282 |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.